The federal Health Department has no capacity to seek out a replacement hormone treatment for transgender men after popular drug Primoteston was removed from the Pharmaceutical Benefits Scheme. The Department of Health, through the Pharmaceutical Benefits Scheme (PBS), previously announced that from February 1st they will no longer subsidise Primoteston, the most common form of medical transition […]
The Western Australian AIDS Council say they are disappointed that the Pharmaceutical Benefits Advisory Committee’s (PBAC) has decided to defer the decision on whether to list Pre-exposure Prophylaxis (PrEP) on the Pharmaceutical Benefits Scheme (PBS). Negotiation between the PBAC and the manufacturers of the drug Tenofovir which is used in PrEP treatment appear to have […]
The United Kingdom will launch a PrEP trial that will allow 10,000 people to access game-changing HIV preventative medication. Britain’s National Health Service had ruled out offering PrEP treatment to help stop the transmission of HIV, but subsequently lost a court battle over the decision. The new £10 million trial with see 10,000 people being […]
